Loading...
*  Prednisolone added to intravenous immunoglobulin treatment improves outcome in children with severe Kawasaki disease | ADC...
Prednisolone added to intravenous immunoglobulin treatment improves outcome in children with severe Kawasaki disease ... Prednisolone added to intravenous immunoglobulin treatment improves outcome in children with severe Kawasaki disease ...
http://ep.bmj.com/content/98/2/77.full
*  College Surgery (Culm Valley)
Intravenous immunoglobulin therapy. Intravenous immunoglobulin therapy may be needed in very severe cases of myositis where ... Intravenous immunoglobulin therapy can produce a rapid improvement in the symptoms of myositis, but it's very expensive and the ... It's given by intravenous infusion (directly into a vein through an intravenous line, needle or catheter) on two occasions two ...
http://collegesurgery.org.uk/p0.html?a=0&sc=hs&op=sa&topic=conditions/articles/myositis&display=Myositis
*  Atypical C-ANCA following high dose intravenous immunoglobulin. | Journal of Clinical Pathology
Six patients treated with high dose intravenous immunoglobulin and 11 receiving replacement doses of immunoglobulin for ... An identical pattern may be observed in patients receiving high dose intravenous immunoglobulin but not in those on replacement ... Three of six patients receiving high dose intravenous immunoglobulin and none of 11 patients on replacement doses were atypical ... RESULTS: 16 of 31 batches of intravenous immunoglobulin from six different manufacturers were atypical C-ANCA positive. ...
http://jcp.bmj.com/content/52/3/177
*  Bridges Medical Practice - Library - Health A-Z
Intravenous immunoglobulin therapy. Intravenous immunoglobulin therapy may be needed in very severe cases of myositis where ... Intravenous immunoglobulin therapy can produce a rapid improvement in the symptoms of myositis, but it's very expensive and the ... It's given by intravenous infusion (directly into a vein through an intravenous line, needle or catheter) on two occasions two ...
http://www.bridgesmedicalpractice.co.uk/Library/Conditions/Articles/myositis/introduction
*  Aseptic Meningitis and Intravenous Immunoglobulin Therapy | Annals of Internal Medicine | American College of Physicians
Intravenous Immunoglobulin to Fight Complex Regional Pain Syndrome: Is Hope Gone? Annals of Internal Medicine; 167 (7): 515-516 ... Low-Dose Intravenous Immunoglobulin Treatment for Long-Standing Complex Regional Pain Syndrome: A Randomized Trial Annals of ... Aseptic Meningitis and Intravenous Immunoglobulin Therapy Curtis L. Scribner, MD; Richard M. Kapit, MD; Evelyne T. Phillips, ... Most recently, as noted by Sekul and colleagues in this issue [4], very high doses of intravenous immunoglobulin (2 g/kg of ...
http://annals.org/aim/article-abstract/707865/aseptic-meningitis-intravenous-immunoglobulin-therapy
*  Intravenous Immunoglobulin (IVIG) | OncoLink
IVIG combines immunoglobulin from the blood of many people to boost, this is used to boost the patient's immune system to fight ... About Intravenous Immunoglobulin (IVIG) What is immunoglobulin?. An immunoglobulin is also known as an antibody. It is a ... It takes the plasma from thousands of people to make a dose of immunoglobulin. This is then given, by intravenous (IV) infusion ... Intravenous Immunoglobulin Intravesicular Mitomycin Intron-A® Iobenguane I-131 Ipilimumab Iressa® Irinotecan Irinotecan ...
https://www.oncolink.org/cancer-treatment/oncolink-rx/intravenous-immunoglobulin-ivig
*  Antenatal intravenous immunoglobulin in c... & related info | Mendeley
Antenatal intravenous immunoglobulin in chronic immune thrombocytopenic purpura: Case report and literature review. *Howman R ... who was successfully managed with the use of weekly intravenous immunoglobulin 1 g/kg without recourse to direct fetal sampling ...
https://www.mendeley.com/research-papers/antenatal-intravenous-immunoglobulin-chronic-immune-thrombocytopenic-purpura-case-report-literature/
*  Intravenous Immunoglobulin (IVIG): uses & side-effects | PatientsLikeMe
Find the most comprehensive real-world treatment information on Intravenous Immunoglobulin (IVIG) at PatientsLikeMe. 217 ... bipolar I disorder or psoriasis currently take Intravenous Immunoglobulin (IVIG). ... Showing 3 of 18 patient evaluations for Intravenous Immunoglobulin (IVIG) Previous page 1 2 3 … 6 Next page ...
https://www.patientslikeme.com/treatment/14576-sandoglobuline-side-effects-and-efficacy
*  Intravenous immunoglobulin for Guillain-Barré syndrome | Cochrane
Intravenous immunoglobulin for Guillain-Barré syndrome. Review question Intravenous immunoglobulin (IVIg) is a treatment in ... Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a review first published in ... 1. To examine the efficacy of intravenous immunoglobulin (IVIg) in hastening recovery and reducing the long-term morbidity from ... Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2014, Issue 9. Art. No.: ...
http://www.cochrane.org/CD002063/NEUROMUSC_intravenous-immunoglobulin-guillain-barre-syndrome
*  Immunotherapy with Intravenous Immunoglobulins | 9780123707253 | VitalSource
Buy or Rent Immunotherapy with Intravenous Immunoglobulins as an eTextbook and get instant access. With VitalSource, you can ... Immunotherapy with Intravenous Immunoglobulins Edition by Imbach, Paul and Publisher Academic Press. Save up to 80% by choosing ...
https://www.vitalsource.com/products/immunotherapy-with-intravenous-immunoglobulins-imbach-paul-v9780123707253
*  Intravenous Immunoglobulin (IVIG) | ONS
Prophylactic intravenous administration of immunoglobulin (IVIG) has been examined in patients with cancer for prevention of ... Immunoglobulin is an antibody in the immune system that identifies and neutralizes foreign items, such as bacteria and viruses ...
https://www.ons.org/intervention/intravenous-immunoglobulin-ivig-0
*  Preventing Intravenous Immunoglobulin-associated Adverse Reactions
Serum levels of immunoglobulin A,. immunoglobulin M and immunoglobulin G will be quantified before and after IVIG-infusion. In ... Prospective Assessment of 0.2 um Pore-sized Filters in Preventing Intravenous Immunoglobulin-associated Adverse Reactions. ... Prospective Assessment of 0.2 um Pore-sized Filters in Preventing Intravenous Immunoglobulin-associated Adverse Reactions ...
http://www.knowcancer.com/cancer-trials/NCT00675805/
*  Intravenous Immunoglobulin (IVIg) Treatment May Benefit Some Children with Autism Spectrum Disorder
The article 'Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism' is published in ... Intravenous Immunoglobulin (IVIg) Treatment May Benefit Some Children with Autism Spectrum Disorder. News provided by ... Intravenous Immunoglobulin (IVIg) Treatment May Benefit Some Children with Autism Spectrum Disorder -- Biomarkers included on ... may benefit from intravenous immunoglobulin (IVIg) treatment, according to new research from Richard E. Frye, MD, PhD, Chief of ...
https://www.prnewswire.com/news-releases/intravenous-immunoglobulin-ivig-treatment-may-benefit-some-children-with-autism-spectrum-disorder-300710602.html
*  Intravenous Immunoglobulins in Complex-regional Pain Syndrome - Full Text View - ClinicalTrials.gov
Immunoglobulins. Antibodies. Immunoglobulins, Intravenous. gamma-Globulins. Rho(D) Immune Globulin. Immunologic Factors. ... Biological: intravenous immunoglobulins 0.36-0.44g/Kg IvIg intravenous, 3x, every 4 weeks ... Biological: intravenous immunoglobulins 0.36-0.44g/Kg IvIg intravenous, 3x, every 4 weeks ... Intravenous Immunoglobulins in Complex-regional Pain Syndrome (PAINLESS). The safety and scientific validity of this study is ...
https://clinicaltrials.gov/ct2/show/NCT00949065?recr=Open&cond=%22Complex+Regional+Pain+Syndromes%22&rank=7
*  Global Intravenous Immunoglobulin (IVIg) Market Research Report 2017
Intravenous Immunoglobulin (IVIg) in Global market, especially in North America, Europe, China, Japan, Latin America and India ... By type, immunoglobulin M (IgM), immunoglobulin G (IgG), immunoglobulin D (IgD), immunoglobulin A (IgA), and immunoglobulin E ( ... 1 Intravenous Immunoglobulin (IVIg) Market Overview. 1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg). 1.2 ... 2.5.1 Intravenous Immunoglobulin (IVIg) Market Concentration Rate. 2.5.2 Intravenous Immunoglobulin (IVIg) Market Share of Top ...
http://www.sbwire.com/press-releases/global-intravenous-immunoglobulin-ivig-market-to-gain-from-increased-incidence-of-autoimmune-diseases-885628.htm
*  Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
Intravenous immunoglobulin, IVIg)," Therapeutic Immunology, vol. 1, no. 5, pp. 269-277, 1994. View at Google Scholar · View at ... "Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis," Experimental ... A. W. Tan, B. Y. Thong, L. W. Yip, H. H. Chng, and S. K. Ng, "High-dose intravenous immunoglobulins in the treatment of toxic ... J.-C. Bystryn, D. Jiao, and S. Natow, "Treatment of pemphigus with intravenous immunoglobulin," Journal of the American Academy ...
https://www.hindawi.com/journals/iji/2016/3523057/ref/
*  Intravenous Immunoglobulin After Relapse in Vasculitis - Full Text View - ClinicalTrials.gov
Immunoglobulins. Antibodies. Immunoglobulins, Intravenous. gamma-Globulins. Rho(D) Immune Globulin. Immunoglobulin G. ... Intravenous Immunoglobulin After Relapse in Vasculitis. The safety and scientific validity of this study is the responsibility ... The aim of this study is to study the efficacy of intravenous immunoglobulins for inducing remission in patients relapsing of ... Intravenous Immunoglobulin After Relapse in Vasculitis (Microscopic Polyangiitis, Wegener's Granulomatosis and SHURG-STRAUSS ...
https://clinicaltrials.gov/ct2/show/NCT00307658
*  Intravenous Immunoglobulin Therapy in Optic Neuritis - Full Text View - ClinicalTrials.gov
Immunoglobulins. Antibodies. Immunoglobulins, Intravenous. gamma-Globulins. Rho(D) Immune Globulin. Immunologic Factors. ... Intravenous Immunoglobulin Therapy in Optic Neuritis. The safety and scientific validity of this study is the responsibility of ... To determine whether high-dose intravenous immunoglobulin (IVIg) is more effective than placebo in restoring lost visual ...
https://clinicaltrials.gov/ct2/show/NCT00000117?cond=%22Optic+neuritis%22&rank=16
*  Intravenous Immunoglobulins in Dermatology 1st edition | 9781841841366 | VitalSource
Buy or Rent Intravenous Immunoglobulins in Dermatology as an eTextbook and get instant access. With VitalSource, you can save ... Intravenous Immunoglobulins in Dermatology 1st Edition by Stephen Jolles and Publisher CRC Press. Save up to 80% by choosing ...
https://www.vitalsource.com/products/intravenous-immunoglobulins-in-dermatology-stephen-jolles-v9780203627051
*  Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins - Full Text View - ClinicalTrials.gov
Drug: intravenous immunoglobulin (IVIg) The intravenous immunoglobulin (brand Privigen) will be infused intravenously, monthly ... Immunoglobulins. Antibodies. Immunoglobulins, Intravenous. gamma-Globulins. Rho(D) Immune Globulin. Immunologic Factors. ... Treatment of Multiple System Atrophy Using Intravenous Immunoglobulins. The safety and scientific validity of this study is the ... This protocol includes administration of intravenous immunoglobulin (IVIg). IVIg contains antibodies derived from human plasma ...
https://clinicaltrials.gov/ct2/show/NCT00750867?term=Multiple+System+Atrophy&rank=5
*  Unilateral Oral Mucous Membrane Pemphigoid: Refractory Atypical Presentation Successfully Treated with Intravenous...
Intravenous immunoglobulin (IVIg) at a dose of 2 g/kg/cycle was started and repeated every three weeks. Complete remission was ... Intravenous immunoglobulin was started and repeated every three weeks. Complete remission was achieved after three cycles and ... Refractory Atypical Presentation Successfully Treated with Intravenous Immunoglobulins. André Laureano and Jorge Cardoso ...
https://www.hindawi.com/journals/cridm/2015/930859/
*  Updated List of High Journal Impact Factor Intravenous Immunoglobulin Journals
Intravenous Immunoglobulins (IVIG) Enhance In vitro Activation of Neutrophils in C57BL/6 but not in CBA Mice� article- ... Intravenous Immunoglobulin. As per available reports about 100 journals, 162 Conferences, 30 workshops are presently dedicated ... As reported in Sudhir Gupta "Intravenous Immunoglobulins (IVIG) Enhance In vitro Activation of Neutrophils in C57BL/6 but not ... to Intravenous Immunoglobulin and about 366282 articles are being published on the current research trends in Intravenous ...
https://www.omicsonline.org/intravenous-immunoglobulin-journals-conferences-list.php
*  High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration - Tabular View - ClinicalTrials.gov
High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration. The safety and scientific validity of this study is the ... High-Dose Intravenous Immunoglobulin to Treat Cerebellar Degeneration. Official Title ICMJE The Efficacy of High-Dose ... Arakawa Y, Yoshimura M, Kobayashi S, Ichihashi K, Miyao M, Momoi MY, Yanagisawa M. The use of intravenous immunoglobulin in ... This study will examine whether high-dose intravenous immunoglobulin (IVIG) is safe and effective for treating cerebellar ...
https://clinicaltrials.gov/ct2/show/record/NCT00034242?term=Ataxias+and+Cerebellar+or+Spinocerebellar+Degeneration
*  Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine
N. Mittmann, B. Chan, S. Knowles, L. Cosentino, and N. Shear, "Intravenous immunoglobulin use in patients with toxic epidermal ... Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine. Carlos Saavedra, ... "Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin," Science, vol. 282, no. ... "Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin," Science, vol. 282, no. ...
https://www.hindawi.com/journals/crii/2012/931528/ref/